Prestigious 2025 Gold Plate Award Goes to Kevin Hochman
CHICAGO, May 18, 2025 /PRNewswire/ — Hundreds of industry leaders were on hand in the Great Hall of Chicago's Union Station on Saturday night, May 17, as Kevin Hochman, CEO & President of Brinker International was awarded the 2025 Gold Plate Award from the IFMA The Food Away from Home Association. Hochman was nominated in the Chain Full Service category by The Coca Cola Company and selected from the eight honorees who took home Silver Plate awards this year.
Hochman became CEO and President of Brinker International, Inc., in 2022. Brinker is one of the world's leading casual dining companies and home of Chili's® Grill & Bar, and Maggiano's Little Italy®. Brinker-owned restaurants serve about 800,000 guests daily, with a workforce of 70,000+. Under Hochman's leadership, the company's market capitalization has increased to over $7 billion.
Hochman was introduced at the awards ceremony by his mentor, Dave Goebel, Chairman of Jack in the Box, who told the attending crowd that 'The combination of Kevin's intellectual capacity, his spirit of inclusiveness, his transparency and authenticity, his heart and genuine concern for the thousands of Chiliheads and Maggiano's team members is core to his success, what brings him here this evening and will serve those brands well for years to come.'
In accepting the Gold Plate, Hochman thanked the many people who have supported him, from his mother, wife, and family to his colleagues and mentors. He said that, reflecting on the great success of Chili's led him to three important realizations, 'One: Dining out is not dead…eating out is as relevant as ever for consumers. Two: If you can do the fundamentals well…you can make your operation a success. And Three: Listen to the front lines. Those closest to the customer can help you make better decisions.'
For 71 years, IFMA The Food Away from Home Association has presented awards to extraordinary foodservice operators through the Gold & Silver Plate Awards, the most respected awards program in foodservice. Each year, the group solicits nominations from across the industry and a distinguished jury of industry experts weighs the merits of candidates who represent a variety of foodservice segments. Selected honorees receive a Silver Plate Award, and one is then chosen by secret ballot to receive the Gold Plate Award for overall industry excellence.
Past Gold Plate winners include Danny Meyer (2000), Van Eure (2004), Charlie Trotter (2008), Timothy J. Dietzler (2010), Wolfgang Puck (2017), Regynald G. Washington (2019), Antionette Watkins (2021), Lance Trenary (2022), Jessica Shelly (2023), and Chris Tomasso (2024).
In addition to Hochman, 2025 Silver Plate recipients are:
Geoff Alexander, President and CEO of Wow Bao, in the category of Grocery, Convenience, & Specialty Retail, nominated by Ecolab
Ryan Conklin, Director & Executive Chef Culinary and Nutrition Services at UNC Health Rex, in the category of Healthcare, nominated by ITW Food Equipment Group
Gary Crompton, President & CEO of Aramark Workplace Experience Group, in the category of Business & Industry / Foodservice Management, nominated by PepsiCo
Whitney Ellersick, Executive Director for Nutrition Services at Hillsboro School District, in the category of Elementary & Secondary Schools, nominated by Nestlé Professional Solutions
Patti Klos, Director of Dining Services at Tufts University, in the category of Colleges & Universities, nominated by ITW Food Equipment Group
Richard Schneider, Chief Development Officer at Areas USA, in the category of Travel & Leisure Foodservice, nominated by Ecolab, Hormel Foods, and Nestlé Professional Solutions
Michael Skipworth, President and CEO of Wingstop, in the category of Chain Limited Service, nominated by Ecolab and Tyson Foods
'It was an honor to present the Gold Plate to Kevin Hochman this year,' said Phil Kafarakis, IFMA The Food Away from Home Association's President & CEO. 'All our winners are nominated by food, beverage, and equipment manufacturer partners who know their stories first-hand. It's a remarkable class of honorees that proves the point that our entire industry is interconnected and stronger together. And it's exciting to realize that these leaders will continue their relationship with us through the Gold & Silver Plate Society, made up of all past award winners.'
The black-tie celebration for the 2025 Silver Plate Class was attended by hundreds of food-away-from-home leaders and luminaries and emceed by the 2022 Gold Plate honoree and CEO of Golden Corral, Lance Trenary. The event opened with the presentation of the National Restaurant Association's Legends Award, presented to Past Golden Corral CEO, Ted Fowler.
Trenary spoke from the heart in honoring Fowler, 'I have had the privilege of having a front row seat to this man's life and as my mentor, my friend, my confidant, my fellow foodie, and my fly-fishing buddy so I can honestly say, I am grateful beyond words.'
IFMA The Food Away from Home Association is currently soliciting candidates for the 2026 Silver Plate Awards. Nominations will be accepted through September. The 2026 Gold & Silver Plate Awards Celebration will be held on Saturday, May 16, 2026. For more information, visit ifmaworld.com.
About IFMA The Food Away from Home AssociationIFMA The Food Away from Home Association is a trade association founded in 1952. The organization empowers, nurtures, and connects an inclusive and diverse $1.5 trillion food-away-from-home ecosystem of manufacturers, distributors, operators, and others. By sharing insights, fostering best practices, and developing networking and educational opportunities through events, IFMA The Food Away from Home Association informs and instructs its members, and motivates change to improve both individual organizations and the food-away-from-home industry at large. For more information, visit ifmaworld.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
an hour ago
- Malaysian Reserve
Conformal Medical Closes $32 Million Series D Extension to Advance its Next-Generation Left Atrial Appendage Occlusion Technology
New partner reinforces confidence in the company's progress and future potential. NASHUA, N.H., Aug. 12, 2025 /PRNewswire/ — Conformal Medical, Inc., a medical device company developing next-generation left atrial appendage occlusion (LAAO) technology, announced the successful closing of its Series D extension financing, with a new partner joining inside investors to raise a total of $32 million. The funds will support the enrollment of the company's ongoing CONFORM Pivotal Trial and fund key pre-commercialization initiatives for CLAAS® AcuFORM™ LAAO system. The CONFORM Pivotal Trial is the company's clinical trial evaluating the safety and efficacy of the CLAAS® System compared to other commercially available LAAO devices and will support U.S. Food and Drug Administration (FDA) pre-market approval. The CLAAS AcuFORM System is designed to seal the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib) to reduce the risk of stroke without the need for anticoagulants. 'We are pleased to have treated over 100 patients with the next-generation AcuFORM™ System, with impressive deliverability and safety performance to date,' said James Reinstein, President and CEO of Conformal Medical. 'We look forward to building upon this robust body of evidence to further validate our one-size strategy, and the promising experience from our GLACE trial, demonstrating successful use of ICE guidance as it would eliminate the need for general anesthesia and intubation for these procedures.' Conformal Medical's proprietary CLAAS AcuFORM technology features a foam-based architecture designed to conform to a broad range of LAA anatomies with only two sizes. The AcuFORM device may also accelerate the shift to ICE-guided LAAO closure due to simplified sizing and seal confirmation, thereby potentially eliminating the need for a procedural transesophageal echocardiogram and general anesthesia. This is a significant advancement with the potential to shift clinical practice to a single-operator procedure that is less invasive for patients. The company remains focused on completing the CONFORM and GLACE clinical trials to demonstrate its safety profile and ability to offer breakthrough solutions that address unmet clinical needs and transform the way Left Atrial Appendage Occlusion is treated. Piper Sandler acted as exclusive financial advisor, and Gunderson Dettmer acted as legal counsel to Conformal Medical in this transaction. About CONFORM Pivotal Trial The CONFORM Pivotal Trial is a prospective, multicenter, randomized controlled study evaluating the safety and efficacy of the Conformal CLAAS AcuFORM System compared to other commercially available left atrial appendage (LAA) devices. The trial plans to randomize approximately 1,600 patients at sites worldwide and is now >30% enrolled. It aims to generate pivotal data supporting next-generation stroke prevention therapies for individuals with non-valvular atrial fibrillation (AFib) who are seeking an alternative to long-term oral anticoagulation. For more information, visit About Conformal Medical Conformal Medical, Inc. is a medical device company developing devices to prevent stroke in patients with non-valvular atrial fibrillation. The company's proprietary technology is intended to make left atrial appendage closure a same-day, single-operator procedure. For more information, visit CAUTION: Investigational Device. The CLAAS System is limited by Federal (or United States) law to investigational use.
Malaysian Reserve
2 hours ago
- Malaysian Reserve
Copan Launches UriVerse™: Fully Automated Solution for Urine Specimen Aliquoting
MURRIETA, Calif., Aug. 12, 2025 /PRNewswire/ — Copan, a leader in microbiology laboratory and automation innovations, proudly announced the official launch of UriVerse™ during the Association for Diagnostics & Laboratory Medicine (ADLM) Clinical Lab Expo in Chicago, IL. UriVerse is a state-of-the-art, fully automated system that transforms the pre-analytical handling of urine specimens by automating key manual steps. UriVerse automates critical steps including de-capping, barcode labeling, aliquoting, and re-capping which helps laboratories reduce manual labor and minimize errors. Revolutionizing Urine Specimen Workflow Urine specimens constitute a significant portion of the laboratory's daily workload, yet key pre-analytical steps like aliquoting are often still performed manually. UriVerse can reduce hands-on time, minimize errors, and help laboratories handle growing urine volumes with greater efficiency and consistency. UriVerse eliminates manual pipetting and sorting with continuous, random-access loading, cup recognition, and automated aliquoting, labeling and capping, all in one platform. A Unique System for Urine Specimen Aliquoting 'Copan continues to pioneer technologies that support the advancement of laboratory automation,' said Fabrizio Mazzocchi, CEO of Copan Diagnostics. 'With UriVerse, we offer an efficient, accurate solution to help laboratories meet rising urine testing demands, particularly in chemistry and toxicology, while reducing variability through the automation of manual pre-analytical tasks.' UriVerse is designed to address the challenges of modern urine testing workflows, especially in laboratories facing increasing volume, limited personnel, and rising expectations for faster turnaround time. By automating these manual processes, UriVerse supports better specimen traceability and fits easily into existing laboratory workflows. UriVerse Now Available in the U.S. Following its successful debut at ADLM, UriVerse is now available in the United States directly through Copan Diagnostics. The new instrument joins Copan's renowned portfolio of automation solutions, including WASP® and WASPLab®, reinforcing the company's commitment to innovation in specimen collection, transport, and pre-analytical automation. About Copan Diagnostics, Inc. Copan Diagnostics is part of Copan Group, a leading global manufacturer of collection and transport systems. Through its collaborative approach, Copan has developed breakthrough technologies such as FLOQSwabs®, ESwab®, UTM® Universal Transport Medium™, and full laboratory automation and artificial intelligence. Copan continues to innovate and transform collection and transport systems, as well as laboratory automation, assisting healthcare providers to improve patient care. For more information, visit
Malaysian Reserve
4 hours ago
- Malaysian Reserve
RepTrak Appoints Thierry D'Hers and Catherine Hernandez-Blades to Board of Directors
BOSTON, Aug. 12, 2025 /PRNewswire/ –The RepTrak Company™, the world's leading provider of reputation intelligence, proudly announces the appointment of Thierry D'Hers and Catherine Hernandez-Blades to its Board of Directors. These strategic appointments underscore RepTrak's commitment to scaling its reputation intelligence suite with cutting-edge technologies, AI-driven insights, and product innovation. Thierry D'Hers Thierry D'Hers brings more than two decades of experience in product innovation, engineering leadership, and advisory roles. He is most known for his foundational role at Tableau, where he helped scale the company's data visualization platform, PowerBI, into a global business intelligence leader. Most recently, he served as Chief Product & Engineering Officer at Vivun. D'Hers has also advised several tech organizations including Pigment, Radar, Indico Labs, and Headwaters Economics — holding strategic roles in both enterprise and mission-driven technology ventures. 'RepTrak is uniquely positioned at the intersection of technology, data, and trust,' said D'Hers. 'I'm excited to join the Board at a time when innovation and AI are reshaping how organizations manage stakeholder perception. I look forward to aiding the growth of the world's most powerful reputation intelligence platform.' Catherine Hernandez-Blades Catherine Hernandez-Blades holds a distinguished track record across the financial services, defense, aerospace, technology, and government sectors. She currently serves as an independent board director for CoreCivic, Inc., where she sits on the Nominating & Governance and Risk Committees. Previously, she held C-suite roles at three Fortune 500 companies: Chief Marketing and Communications Officer at SAIC, Aflac, and Flex. In addition, she is an EMMY® winner, Cannes Lions recipient, Forbes Top 50 Global CMO, and the first and only American recipient of the Relations 4 the Future medal at Davos. 'Having relied on RepTrak's products and services for over a decade across multiple Fortune 500 companies, I can personally attest to the platform's immense value. It not only quantifies the business impact driven by teams but also plays a crucial role in strategic decision-making — extending its influence to the entire C-suite and Board of Directors. I'm particularly excited about the innovative new products in development and am delighted to join RepTrak's board.' Fueling Product and Platform Evolution These appointments reflect a deliberate move to accelerate the evolution of RepTrak's recently launched platform, Compass™ — deepening its technology, product, governance, and communications expertise. D'Hers and Hernandez-Blades bring strengths that will help guide RepTrak through its next phase of growth and innovation. 'Thierry and Catherine bring distinct and deeply aligned expertise to RepTrak. Thierry's product and AI leadership, paired with Catherine's global reputation leadership, governance insight, and ESG acumen, position us to serve clients with sharper intelligence, deeper trust, and greater value than ever before. We are proud to welcome them both to the Board' says Mark Sonders, CEO of The RepTrak Company. About The RepTrak Company The RepTrak Company is the world's premier provider of reputation data and insights, helping businesses harness reputation intelligence to secure competitive advantage. RepTrak's predictive insights enable subscribers to safeguard business value, optimize ROI, and amplify their positive societal impact. Combining advanced metrics with dedicated reputation advisors, RepTrak delivers actionable analyses that align business goals with stakeholder sentiment across global markets and diverse industries. Established in 2004, The RepTrak Company owns the world's largest reputation benchmarking database, gathering over 1 million company ratings per year used by CEOs, boards, and executives in more than 60 countries worldwide. For more information, please visit About RepTrak Compass Compass is the only truly integrated global solution for reputation intelligence — combining RepTrak's world-class Global Advisory expertise with AI-enabled navigation. Designed for today's dynamic stakeholder environment, Compass enables leaders to shift from measuring reputation to actively shaping it. RepTrak invites communications, corporate affairs, brand, and reputation leaders around the world to explore Compass — and see how it empowers them to lead reputation, not just report on it. To learn more about Compass, visit
